Expression of human immunodeficiency virus type 1 (HIV-1) gag, pol, and env proteins from chimeric HIV-1-poliovirus minireplicons.
about
The rhinovirus type 14 genome contains an internally located RNA structure that is required for viral replication.Therapeutic Use of Native and Recombinant EnterovirusesSubgenomic replicons of the flavivirus Kunjin: construction and applicationsIntestinal M cells: the fallible sentinels?A poliovirus replicon containing the chloramphenicol acetyltransferase gene can be used to study the replication and encapsidation of poliovirus RNAPolioviruses containing picornavirus type 1 and/or type 2 internal ribosomal entry site elements: genetic hybrids and the expression of a foreign geneMutation of the aspartic acid residues of the GDD sequence motif of poliovirus RNA-dependent RNA polymerase results in enzymes with altered metal ion requirements for activity.Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in transCapsid coding sequence is required for efficient replication of human rhinovirus 14 RNARelease of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 GagToward a poliovirus-based simian immunodeficiency virus vaccine: correlation between genetic stability and immunogenicityEnzymatic activity of poliovirus RNA polymerases with mutations at the tyrosine residue of the conserved YGDD motif: isolation and characterization of polioviruses containing RNA polymerases with FGDD and MGDD sequencesComplementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in transEncapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infectionA poliovirus minireplicon containing an inactive 2A proteinase is expressed in vaccinia virus-infected cellsPoliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation.Expression of foreign proteins by poliovirus polyprotein fusion: analysis of genetic stability reveals rapid deletions and formation of cardioviruslike open reading frames.Expression of an antigenic adenovirus epitope in a group B coxsackievirus.Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.Inherent instability of poliovirus genomes containing two internal ribosome entry site (IRES) elements supports a role for the IRES in encapsidation.Novel design architecture for genetic stability of recombinant poliovirus: the manipulation of G/C contents and their distribution patterns increases the genetic stability of inserts in a poliovirus-based RPS-Vax vector system.Expression of a membrane-anchored glycoprotein, the influenza virus hemagglutinin, by dicistronic replicons derived from the poliovirus genomeEncapsidation and serial passage of a poliovirus replicon which expresses an inactive 2A proteinaseAn aspartic acid at amino acid 108 is required to rescue infectious virus after transfection of a poliovirus cDNA containing a CGDD but not SGDD amino acid motif in 3Dpol
P2860
Q24539314-9C83D16B-C7D0-4DFB-8A2A-182DACD5E847Q26767082-CDB940DB-8203-481E-9E4B-E266E28F1049Q27480783-666AC972-2A0F-4D85-B5E4-234E39B07709Q30050457-19D2BB4D-96B6-42C8-9881-ABE345519257Q34236355-4E3CCACE-40A4-41F8-BB75-17F6D3546EA2Q35047782-A90863B5-4961-43B1-AA71-54B388C57E8CQ35834149-C3D62B4E-473D-44FC-8B44-E53980AF94FFQ35834209-EDE65AA7-983F-40CF-9A1C-A8DF937CCB73Q35857542-1C6EFF7E-028D-4145-9283-F18BACF7AB8FQ35859503-1E0EC063-411C-4D42-B846-2AECE8BFAC39Q35896058-A74F2814-AF92-4A66-AF54-C43CA3347A03Q36639608-451631D9-A3DA-479A-93A9-F990A7DC0CD1Q36649283-3D835507-91E5-4F5D-925B-7C03651EDA33Q36649407-2AC5C829-1B23-4FCF-A4A4-B348F31DBDE6Q36650966-5F4A8C23-BACE-4DCF-AB0B-8DA98DF665C6Q36655208-F8D0CAC7-55A9-49E9-BAA9-48B5791ABCD0Q39577039-E6FAF5FD-0F6F-4BC1-876C-418E23E0D762Q39591041-7F570AFC-B787-4ADC-A272-DA8550C37911Q39605695-FC7FFB00-111E-45D3-B8AD-F49BAA04FC0EQ39612197-27C7D767-08D3-4F98-80FF-2E229BA8D9A7Q39682504-46D21D75-D2BA-4DE8-A89E-C39928A404B3Q39683439-7A9B9726-4102-42E3-96E5-292172067591Q39868975-92966241-BDAF-4718-906C-A088C3EE9D6DQ39872900-F053E4BE-E2AB-47E6-BB0F-AF6A7EB8A907
P2860
Expression of human immunodeficiency virus type 1 (HIV-1) gag, pol, and env proteins from chimeric HIV-1-poliovirus minireplicons.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Expression of human immunodefi ...... IV-1-poliovirus minireplicons.
@ast
Expression of human immunodefi ...... IV-1-poliovirus minireplicons.
@en
type
label
Expression of human immunodefi ...... IV-1-poliovirus minireplicons.
@ast
Expression of human immunodefi ...... IV-1-poliovirus minireplicons.
@en
prefLabel
Expression of human immunodefi ...... IV-1-poliovirus minireplicons.
@ast
Expression of human immunodefi ...... IV-1-poliovirus minireplicons.
@en
P2093
P2860
P1433
P1476
Expression of human immunodefi ...... IV-1-poliovirus minireplicons.
@en
P2093
P2860
P304
P407
P577
1991-06-01T00:00:00Z